Dominik Kłudkiewicz

Dominik Kłudkiewicz

Auto-generated profile, based on publicly available information

Dominik Kłudkiewicz


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 June 2025 in Acta Poloniae Pharmaceutica - Drug Research
Verified
Journal Article
Open access
RLRobert Lipka
Robert Lipka
MPMagdalena Piekart
Magdalena Piekart
DKDominik Kłudkiewicz
Dominik Kłudkiewicz
ASAgnieszka Sawicka
Agnieszka Sawicka
In EDDA (ethylenediamino-N,N'-diacetic acid), two main impurities, 2-oxopiperazine-1-ylacetic acid (OPPAA) and N-(2-aminoethylglycine) (AEG), were identified by LC-MS analysis. OPPAA is not commercially available. It was therefore synthesised and its structure was confirmed by elemental, 1H NMR, FT-IR and MS analysis, and an HPLC method with UV detection was developed to test its purity. It turned out that UV detection was inadequate for the analysis of EDDA purity - the results were not consistent with those obtained by titration and 1H NMR. Therefore, a method based on refractometric detection (RID) was developed. Validation of the method was performed, assessing system suitability (SST), limits of detection (LOD) and quantitation (LOQ), linearity, accuracy, precision and robustness. For both contaminants (AEG and OPPAA), a detection limit of 0.02% was achieved. A linear relationship between the signal of both contaminants was observed in the range of LOQ to 0.5 % vs EDDA. The method has satisfactory linearity and accuracy for both impurities and acceptable precision. The results obtained by three analysts were compared using statistical tests. Using refractometric detection, the results of OPPAA determination based on HPLC purity (as a percentage of the OPPAA peak area relative to the area of all signals) and relative to the standard are very similar.